Intranasal endoscopic silicone intubation for congenital obstruction of the nasolacrimal duct in children.
Aim of the present study was to determine the efficacy of intranasal endoscopic silicone intubation to treat congenital nasolacrimal duct obstruction in children who failed conventional lacrimal system probing. Silicone intubation with intranasal endoscopic visualization was performed in 18 eyes of 16 patients with an age range of 18-48 months (mean, 25 months) to treat congenital nasolacrimal duct obstruction. Out of 16 patients, ten had already undergone previous probings with failure, the other six were primary intubation cases without any previous probings. The tubes were left in place an average of 6 months. Follow-up ranged from 4 months to 2 years (mean, 12 months) following removal of the silicone tubing. Intranasal endoscopic silicone intubation is effective in the treatment of congenital nasolacrimal duct obstruction as a primary procedure in children over 18 months of age and, it is also recommended as the next step in the management of epiphora which fails to resolve after probing.
Orhan
M
M
Hacettepe University, Medical Faculty, Ophthalmology Department, Ankara, Turkey.
Onerci
M
M
D002675:Child, Preschool; D003608:Dacryocystorhinostomy; D004724:Endoscopy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007440:Intubation / Q000295:instrumentation*; D007767:Lacrimal Duct Obstruction / Q000151:congenital*; D008297:Male; D009301:Nasolacrimal Duct / Q000601:surgery*; D011446:Prospective Studies; D012828:Silicones
D012828:Silicones